Assessment of Circulating CCR6 Level in Acute Myocardial Infarction and its Association with Disease Severity

Amira Mohamed Noureldin Abdelrahman1, Amal Elmahdy Mohamed1, Ahmed Mahmoud Bendary2

  • 1Department of Clinical and Chemical Pathology, Faculty of Medicine, Benha University, Egypt.

Insights

Higher expression of chemokine receptor CCR6 (Ccr6) on lymphocytes was found in acute myocardial infarction (AMI) patients. This finding suggests CCR6 may be a biomarker for AMI severity and coronary artery disease progression.

Area of Science:

  • Cardiovascular Medicine
  • Immunology
  • Biomarker Discovery

Background:

  • Acute myocardial infarction (AMI) involves systemic and intraplaque inflammation, often triggered by coronary artery thrombosis.
  • The G-protein-coupled chemokine receptor (Ccr6) is expressed on leukocytes within atherosclerotic plaques and acts as an inflammation mediator.

Purpose of the Study:

  • To quantify CCR6 lymphocyte expression in AMI patients.
  • To investigate the association between CCR6 expression and AMI severity using the Gensini scoring system.

Main Methods:

  • Flow cytometry was used to measure circulating CCR6+ lymphocytes in 25 AMI patients and 25 controls.
  • Multivariate logistic regression analysis was employed to assess the predictive value of CCR6 for AMI.

Main Results:

  • AMI patients exhibited a significantly higher percentage of CCR6+ lymphocytes compared to controls.
  • CCR6 expression positively correlated with the Gensini score (GS), indicating a link to coronary artery disease (CAD) severity.

Conclusions:

  • CCR6 is an independent biomarker for AMI.
  • CCR6 may facilitate T lymphocyte recruitment, potentially destabilizing coronary lesions.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
20
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
32
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
134
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
226
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
53
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
18